Nyxoah
Patrick Tompkins has over 20 years of executive leadership experience in the medical device space. He joined Nyxoah in 2020 as VP of US Operations with responsibility for managing Nyxoah’s US operations in their IDE trial. Patrick has previous commercial leadership experience, both with global and domestic responsibilities in the cardiac and neuro fields. The last 13 years with neuromodulation companies, 8 of which were with St Jude Medical. Patrick has introduced and led the commercialization efforts, of first to market innovative technologies in both the cardiac and the neuromodulation spaces.
This person is not in the org chart
This person is not in any offices
Nyxoah
Nyxoah is a medical device company focused on the development and commercialization of a hypoglossal nerve stimulation (HGNS) therapy.